Advent, a leading global private equity investor, today announced that funds managed by Advent have signed a definitive agreement to invest USD $175 million via primary and secondary for a significant ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...